These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2551477)

  • 1. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas.
    Le Doussal V; Tubiana-Hulin M; Friedman S; Hacene K; Spyratos F; Brunet M
    Cancer; 1989 Nov; 64(9):1914-21. PubMed ID: 2551477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy.
    Amat S; Penault-Llorca F; Cure H; Le Bouedëc G; Achard JL; Van Praagh I; Feillel V; Mouret-Reynier MA; Dauplat J; Chollet P
    Int J Oncol; 2002 Apr; 20(4):791-6. PubMed ID: 11894126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear characteristics as indicators of prognosis in node negative breast cancer patients.
    le Doussal V; Tubiana-Hulin M; Hacene K; Friedman S; Brunet M
    Breast Cancer Res Treat; 1989 Nov; 14(2):207-16. PubMed ID: 2605347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems.
    Genestie C; Zafrani B; Asselain B; Fourquet A; Rozan S; Validire P; Vincent-Salomon A; Sastre-Garau X
    Anticancer Res; 1998; 18(1B):571-6. PubMed ID: 9568179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count.
    Tawfik O; Kimler BF; Davis M; Stasik C; Lai SM; Mayo MS; Fan F; Donahue JK; Damjanov I; Thomas P; Connor C; Jewell WR; Smith H; Fabian CJ
    Virchows Arch; 2007 Jun; 450(6):627-36. PubMed ID: 17458558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential identification of factors predicting distant relapse in breast cancer patients treated by conservative surgery.
    Tubiana-Hulin M; Le Doussal V; Hacene K; Rouëssé J; Brunet M
    Cancer; 1993 Aug; 72(4):1261-71. PubMed ID: 8393370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proposal for a new histological classification scheme for predicting short-term tumor recurrence and death in patients with invasive ductal carcinoma of the breast.
    Hasebe T; Imoto S; Sasaki S; Mukai K
    Jpn J Cancer Res; 1998 Dec; 89(12):1358-73. PubMed ID: 10081498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor.
    Clayton F
    Cancer; 1991 Sep; 68(6):1309-17. PubMed ID: 1651805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: multivariate analysis with Ki-67 index, mitotic count, and microvessel density.
    Mandard AM; Denoux Y; Herlin P; Duigou F; van De Vijver MJ; Clahsen PC; van Den Broek L; Sahmoud TM; Henry-Amar M; van De Velde CJ
    Cancer; 2000 Oct; 89(8):1748-57. PubMed ID: 11042570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer?
    Chollet P; Amat S; Belembaogo E; Curé H; de Latour M; Dauplat J; Le Bouëdec G; Mouret-Reynier MA; Ferrière JP; Penault-Llorca F
    Br J Cancer; 2003 Oct; 89(7):1185-91. PubMed ID: 14520443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic correlates of prognosis in lymph node-positive breast carcinomas.
    Clayton F; Hopkins CL
    Cancer; 1993 Mar; 71(5):1780-90. PubMed ID: 8383579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A newly proposed semi-automated method of grading invasive lobular carcinoma: a unifying concept and correlation with prognostic markers and patient survival.
    Stevens E; Kimler BF; Davis MK; Fan F; Thomas P; Wang XY; Damjanov I; Tawfik OW
    Ann Clin Lab Sci; 2009; 39(1):25-31. PubMed ID: 19201737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grading and prognosis of invasive ductal mammary carcinoma by nuclear image analysis in tissue sections.
    Kunze KD; Haroske G; Dimmer V; Meyer W; Theissig F
    Pathol Res Pract; 1989 Nov; 185(5):689-93. PubMed ID: 2560542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study.
    de Nonneville A; Gonçalves A; Zemmour C; Cohen M; Classe JM; Reyal F; Colombo PE; Jouve E; Giard S; Barranger E; Sabatier R; Bertucci F; Boher JM; Houvenaeghel G
    Eur J Cancer; 2017 Oct; 84():34-43. PubMed ID: 28780480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the Scarff-Bloom-Richardson tumor grading system to fine-needle aspirates of the breast.
    Howell LP; Gandour-Edwards R; O'Sullivan D
    Am J Clin Pathol; 1994 Mar; 101(3):262-5. PubMed ID: 8135179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index.
    Meyer JS; Alvarez C; Milikowski C; Olson N; Russo I; Russo J; Glass A; Zehnbauer BA; Lister K; Parwaresch R;
    Mod Pathol; 2005 Aug; 18(8):1067-78. PubMed ID: 15920556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the prognostic significance of current and modified histological grades in breast carcinomas.
    Charpin C; Bacquie N; Bouvier C; Devictor B; Boulat J; Andrac L; Lavaut MN; Allasia C; Piana L
    Anticancer Res; 1995; 15(6B):2611-7. PubMed ID: 8669834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
    Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
    Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic effect of histological tumor grade in node-negative breast cancer patients.
    Schumacher M; Schmoor C; Sauerbrei W; Schauer A; Ummenhofer L; Gatzemeier W; Rauschecker H
    Breast Cancer Res Treat; 1993; 25(3):235-45. PubMed ID: 8369525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of c-erbB2 in primary breast carcinomas: a study on 942 cases.
    Quénel N; Wafflart J; Bonichon F; de Mascarel I; Trojani M; Durand M; Avril A; Coindre JM
    Breast Cancer Res Treat; 1995 Sep; 35(3):283-91. PubMed ID: 7579499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.